Oklahoma City-based Moleculera Labs Inc, which tests for autoimmune neurologic onditions in children and adults, has raised $1.06 million in funding.
Moleculera Labs Inc. recently received a $1.06 million investment from i2E Inc., SeedStep Angel investors and other investors.
i2E, Inc., recently led a $1.06 million investment in Oklahoma City-based Moleculera Labs, Inc., through its Accelerate Oklahoma! Fund.
Associated Material Processing LLC has received a $400,000 investment for the development of a material that removes problem elements from industrial waste streams and drinking water.
SeedStep Angels members have invested $7,155,421 in 32 companies, almost entirely in seed stage. These angels bring much more than money to a deal.
WeGoLook provides affordable on-site verification and inspection services and custom tasking to individuals and businesses. With almost 18,000 agents worldwide — it’s the crowdsourcing model on steroids.
i2E, Inc., and Cowboy Technologies, LLC, recently co-led a $400,000 investment in Stillwater-based Associated Material Processing, LLC, which is advancing technology that eliminates harmful elements from drinking water.
Heather Fahlenkamp is an associate professor in the School of Chemical Engineering at Oklahoma State University. She recently was honored with the 2015 Researcher of the Year award from the Oklahoma Bioscience Association.
The entrepreneurs of East Central University dominated the small business plan category of the 2015 Donald W. Reynolds Governor’s Cup competition with first-, second- and third-place awards.
At this year’s Governor’s Cup competition, it seemed like more students than ever were really wanting to move forward with their business plans. Pulse LLC from the University of Central Oklahoma is one of those teams.
Aircare International announced that it would begin offering an aqueous-based class-D fire-extinguishing agent as part of its aircraft safety product line to combat in-flight lithium battery fires for business and commercial aircraft.
EyeCRO LLC and NeuMedics Inc. announced the formation of a collaboration to facilitate development of NM108, a first-in-class small molecule to treat a number of ophthalmic disorders that lead to blindness, including Diabetic Retinopathy.
i2E and Accele Venture capital recently lead a $2.2 million investment in Pamilco Biopharma. i2E invested t through its Oklahoma Seed Capital Fund.
OCAST has teamed with GE and the Oklahoma School for Science and Mathematics in a STEM education initiative. Listen to the Oklahoma Innovations radio show for details.